rs121918420
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_021957.4(GYS2):c.1436C>A(p.Pro479Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000875 in 1,599,262 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_021957.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GYS2 | NM_021957.4 | c.1436C>A | p.Pro479Gln | missense_variant | Exon 12 of 16 | ENST00000261195.3 | NP_068776.2 | |
GYS2 | XM_024448960.2 | c.1436C>A | p.Pro479Gln | missense_variant | Exon 12 of 17 | XP_024304728.1 | ||
GYS2 | XM_006719063.4 | c.1205C>A | p.Pro402Gln | missense_variant | Exon 11 of 15 | XP_006719126.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GYS2 | ENST00000261195.3 | c.1436C>A | p.Pro479Gln | missense_variant | Exon 12 of 16 | 1 | NM_021957.4 | ENSP00000261195.2 | ||
ENSG00000285854 | ENST00000647960.1 | n.*1438C>A | non_coding_transcript_exon_variant | Exon 19 of 23 | ENSP00000497202.1 | |||||
ENSG00000285854 | ENST00000647960.1 | n.*1438C>A | 3_prime_UTR_variant | Exon 19 of 23 | ENSP00000497202.1 |
Frequencies
GnomAD3 genomes AF: 0.0000989 AC: 15AN: 151694Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000651 AC: 16AN: 245762Hom.: 0 AF XY: 0.0000678 AC XY: 9AN XY: 132798
GnomAD4 exome AF: 0.0000864 AC: 125AN: 1447568Hom.: 0 Cov.: 26 AF XY: 0.0000846 AC XY: 61AN XY: 720614
GnomAD4 genome AF: 0.0000989 AC: 15AN: 151694Hom.: 0 Cov.: 32 AF XY: 0.0000675 AC XY: 5AN XY: 74058
ClinVar
Submissions by phenotype
Glycogen storage disorder due to hepatic glycogen synthase deficiency Pathogenic:5
Variant summary: GYS2 c.1436C>A (p.Pro479Gln) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.5e-05 in 245762 control chromosomes (gnomAD). c.1436C>A has been reported in the literature as a compound heterozygous genotype in at least five individuals affected with Glycogen Storage Disorder type 0, including at least two cases where it was confirmed to be in trans with a pathogenic variant (e.g. Orho_1998, Tagliaferri_2022). These data indicate that the variant is likely to be associated with disease. Experimental evidence evaluating an impact on protein function found that the variant resulted in no detectable glycogen synthase activity (Orho_1998). The following publications have been ascertained in the context of this evaluation (PMID: 9691087, 35854365). Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic (n=2)/likely pathogenic (n=1) and VUS (n=1). Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
ClinVar contains an entry for this variant (Variation ID: 16051). For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects GYS2 function (PMID: 9691087). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This missense change has been observed in individual(s) with glycogen storage disease type 0 (PMID: 9691087). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs121918420, gnomAD 0.03%). This sequence change replaces proline, which is neutral and non-polar, with glutamine, which is neutral and polar, at codon 479 of the GYS2 protein (p.Pro479Gln). -
- -
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.006%). Functional studies provide moderate evidence of the variant having a damaging effect on the gene or gene product (PMID: 9691087). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.85; 3Cnet: 0.98). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with GYS2 related disorder (ClinVar ID: VCV000016051 / PMID: 9691087). The variant has been reported to be in trans with a pathogenic variant as either compound heterozygous or homozygous in at least one similarly affected unrelated individual (PMID: 9691087). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -
not provided Pathogenic:1
Published expression studies demonstrate that variant is associated with no detectable glycogen synthase activity (Orho et al., 1998); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 9691087) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at